FDA
-
-
-
-
-
-
-
WuXi Biologics Reports Record 2025 Annual Results
-
-
-
-
-
-
-
Three WuXi Biologics Manufacturing Facilities Receive GMP Certification from Türkiye İlaç ve Tıbbi Cihaz Kurumu (TITCK)
-
-
-
-
-
-
-
WuXi Biologics Receives CDMO Leadership Awards for Eighth Consecutive Year
-
-
-
-
-
-
-
WuXi XDC Congratulates EDDC on FDA Clearance of IND Application for First Made-in-Singapore Antibody-Drug Conjugate
-
-
-
-
-
-
-
WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility
-
-
-
-
-
-
-
Exelixis (EXEL) Enters into Exclusive License Agreement with WuXi Biologics to Support Further Expansion of its Growing Oncology Biologics Pipeline
-
-
-
-
-
-
-
WuXi Biologics Achieved Remarkable Results in 2019
-
323,577 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

